INTERNATIONAL PATENT: AVENTIS INC. FILES APPLICATION FOR "NK CELLS HAVING REDUCED CD38 EXPRESSION AND METHOD FOR PRODUCING"

GENEVA, March 11 -- AVENTIS INC. (55 Corporate DriveBridgewater, NJ 08807) filed a patent application (PCT/US2025/044288) for "NK CELLS HAVING REDUCED CD38 EXPRESSION AND METHOD FOR PRODUCING" on Aug 29, 2025. With publication no. WO/2026/050706, the details related to the patent application was published on Mar 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BORGES, Christopher (c/o Sanofi450 Water StreetCambridge, Massachusetts 02141), GENGA, Ryan (c/o Sanofi450 Water StreetCambridge, Massachusetts 02141), GRELLA, Alexandra (c/o Sanofi450 Water StreetCambridge, Massachusetts 02141), HO...